Multiple resistance in Gram-negative bacteria

被引:9
作者
Hawkey, PM [1 ]
Munday, CJ
机构
[1] Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England
[2] Hlth Protect Agcy W Midlands Publ Hlth Lab, Birmingham Heartlands & Solihull NHS Trust, Birmingham B9 5SS, W Midlands, England
关键词
antibiotic resistance; extended-spectrum beta-lactamase; carbapenemase; fluoroquinolone resistance; plasmid; integron;
D O I
10.1097/01.revmedmi.0000131427.13353.7f
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
When extended spectrum cephalosporins were introduced into clinical practice some 20 years ago it was widely predicted that these agents would effectively remove the problem of infections caused by resistant Enterobacteriaceae. It very rapidly became clear that the rapid evolution of antibiotic resistance genes in Gram-negative bacteria, particularly with their fluid gene pool, could circumvent the pharmaceutical industry's efforts. In the last 10 years, extended-spectrum beta-lactamases have become the major mechanism of resistance in Enterobacteriaceae to these valuable antimicrobials. In many parts of the world resistance levels have reached the point where these agents can no longer be used, this has resulted in greatly increased usage of fluoroquinolones and carbepenem antibiotics and, once again, a variety of mechanisms of resistance have been recognized which are becoming increasingly common. The review discusses various aspects of the molecular evolution of resistance to these three major groups of antibiotics and reviews the role of mobile elements in Gram-negative bacteria in the dissemination of genes encoding resistance to these classes of antimicrobial. It is concluded that there is already a growing problem of potentially untreatable infections caused by Enterobacteriaceae and Pseudomonas aeruginosa which, unless novel agents are introduced, could pose a major threat to the health of both hospitalized patients and, with the movement of these genes into faecally carried community Gram-negative bacteria, patients with infections in the community. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 114 条
  • [1] A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP)
    ARAKAWA, Y
    MURAKAMI, M
    SUZUKI, K
    ITO, H
    WACHAROTAYANKUN, R
    OHSUKA, S
    KATO, N
    OHTA, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1612 - 1615
  • [2] SHV-16, a β-lactamase with a pentapeptide duplication in the omega loop
    Arpin, C
    Labia, R
    Andre, C
    Frigo, CC
    El Harrif, Z
    Quentin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2480 - 2485
  • [3] Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia
    Avison, MB
    Higgins, CS
    von Heldreich, CJ
    Bennett, PM
    Walsh, TR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 413 - 419
  • [4] Countrywide spread of CTX-M-3 extended-spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland
    Baraniak, A
    Fiett, J
    Sulikowska, A
    Hryniewicz, W
    Gniadkowski, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 151 - 159
  • [5] Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland
    Baraniak, A
    Fiett, J
    Hryniewicz, W
    Nordmann, P
    Gniadkowski, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 393 - 396
  • [6] Origin and evolution of the AmpC β-lactamases of Citrobacter freundii
    Barlow, M
    Hall, BG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1190 - 1198
  • [7] SINGLE AMINO-ACID SUBSTITUTION BETWEEN SHV-1 BETA-LACTAMASE AND CEFOTAXIME-HYDROLYZING SHV-2 ENZYME
    BARTHELEMY, M
    PEDUZZI, J
    BENYAGHLANE, H
    LABIA, R
    [J]. FEBS LETTERS, 1988, 231 (01): : 217 - 220
  • [8] CLOSE AMINO-ACID-SEQUENCE RELATIONSHIP BETWEEN THE NEW PLASMID-MEDIATED EXTENDED-SPECTRUM BETA-LACTAMASE-BULLET-MEN-1 AND CHROMOSOMALLY ENCODED ENZYMES OF KLEBSIELLA-OXYTOCA
    BARTHELEMY, M
    PEDUZZI, J
    BERNARD, H
    TANCREDE, C
    LABIA, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (01) : 15 - 22
  • [9] Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance
    Bauernfeind, A
    Stemplinger, I
    Jungwirth, R
    Giamarellou, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 221 - 224
  • [10] Comparative characterization of the cephamycinase bla(CMY-1) gene and its relationship with other beta-lactamase genes
    Bauernfeind, A
    Stemplinger, I
    Jungwirth, R
    Wilhelm, R
    Chong, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) : 1926 - 1930